IN2012DN00878A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00878A
IN2012DN00878A IN878DEN2012A IN2012DN00878A IN 2012DN00878 A IN2012DN00878 A IN 2012DN00878A IN 878DEN2012 A IN878DEN2012 A IN 878DEN2012A IN 2012DN00878 A IN2012DN00878 A IN 2012DN00878A
Authority
IN
India
Prior art keywords
allergies
probiotic
symptoms
composition
children
Prior art date
Application number
Inventor
Sebastien Holvoet
Annick Mercenter
Adrian Zuercher
Anurag Singh
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42778049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00878(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00878A publication Critical patent/IN2012DN00878A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

A complete nutritional composition comprising Lactococcus strains or probiotic is provided for reducing the symptoms of allergies in different groups of patients such as allergies originating from food allergens in young children or infants and respiratory allergens in children,adults and household pets. Preferably the composition reduces symptoms of allergies (secondary prevention) while not significantly affecting sensitization (primary prevention). The composition comprises a probiotic of the genus Lactococcus.
IN878DEN2012 2009-08-18 2010-08-13 IN2012DN00878A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09168053 2009-08-18
EP09170599 2009-09-17
PCT/EP2010/061803 WO2011020780A1 (en) 2009-08-18 2010-08-13 A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children.

Publications (1)

Publication Number Publication Date
IN2012DN00878A true IN2012DN00878A (en) 2015-05-22

Family

ID=42778049

Family Applications (1)

Application Number Title Priority Date Filing Date
IN878DEN2012 IN2012DN00878A (en) 2009-08-18 2010-08-13

Country Status (16)

Country Link
US (1) US9049881B2 (en)
EP (1) EP2467031B1 (en)
CN (1) CN102695427B (en)
AU (1) AU2010285068B2 (en)
BR (1) BR112012003706A2 (en)
CA (1) CA2770099A1 (en)
CL (1) CL2012000417A1 (en)
ES (1) ES2518490T3 (en)
IN (1) IN2012DN00878A (en)
MX (1) MX2012002039A (en)
PL (1) PL2467031T3 (en)
PT (1) PT2467031E (en)
SG (1) SG178139A1 (en)
TW (1) TW201117733A (en)
WO (1) WO2011020780A1 (en)
ZA (1) ZA201202009B (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
MX2014000458A (en) * 2011-07-12 2014-05-01 Nestec Sa Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs.
US20130084271A1 (en) * 2011-10-03 2013-04-04 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
EP2617296A1 (en) * 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
EP2945494B1 (en) 2013-01-21 2017-03-08 ETH Zürich Baby food composition comprising viable propionic acid-producing bacteria and viable lactic acid-producing bacteria
AU2014212003C1 (en) 2013-02-04 2020-07-16 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
RU2722482C2 (en) 2013-11-25 2020-06-01 Серес Терапеутикс, Инк. Synergistic bacterial compositions and methods for preparing and using them
WO2015095241A2 (en) * 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
EP3212191B1 (en) * 2014-10-28 2022-10-05 Medlab IP Pty Ltd. Treatment for depression and depressive disorders
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
LT3258962T (en) * 2015-02-20 2023-02-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
KR20200040277A (en) 2017-08-14 2020-04-17 세레스 테라퓨틱스, 인코포레이티드 Composition and method for treatment of cholestatic disease
US11883445B2 (en) 2018-03-14 2024-01-30 Emory University Lactococcus bacteria and uses thereof
CN109212129A (en) * 2018-06-30 2019-01-15 湖北海纳天鹰科技发展有限公司 A kind of destination selecting method and device for evading aeroallergen
CN113507844A (en) 2019-01-23 2021-10-15 前品牌股份有限公司 Method for preparing mixed allergen composition
JP2024506678A (en) * 2021-02-23 2024-02-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Compositions and kits for alleviating symptoms of respiratory allergies in infants

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946488B2 (en) 1978-08-07 1984-11-13 極東脂肪酸株式会社 Allergic reaction inhibitor
GB2077101B (en) 1980-05-12 1984-08-08 Kyokuto Fatty Acid Corp Antiallergic composition containing streptococci
FI104465B (en) * 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
CN1149969A (en) 1996-09-18 1997-05-21 任圣启 Technique for producing breast milk-like series health products
ATE206873T1 (en) * 1997-01-09 2001-11-15 Nestle Sa CEREAL PRODUCT CONTAINING PROBIOTICS
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
JP4308481B2 (en) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 Antiallergic agent
AU2004227998A1 (en) 2003-04-02 2004-10-21 Pharmachem Laboratories, Inc. Novel probiotic compositions and methods of using the same
JP4589618B2 (en) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 Lactic acid bacteria and their components inducing immunoregulatory functions
JP2006028050A (en) 2004-07-14 2006-02-02 Combi Corp Skin allergy suppressing composition
WO2006097949A1 (en) 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
US20080003329A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
NL1032840C2 (en) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotic hydrolyzate food for children.
ES2399993T3 (en) * 2007-03-02 2013-04-04 Protectimmun Gmbh Pharmaceutical composition for protection against allergies and inflammatory diseases
CN101715303A (en) * 2007-04-27 2010-05-26 格伦多拉无添加果汁公司 Fruit drink with probio
CN101328468B (en) * 2007-06-21 2012-05-23 东宇生物科技股份有限公司 Antiallergic lactic acid bacteria
FI20075539L (en) * 2007-07-12 2009-01-13 Valio Oy Lactic acid bacteria with proinflammatory properties
JP2009060800A (en) 2007-09-04 2009-03-26 Tsujido Kagaku Kk Food composition
WO2009082216A1 (en) 2007-12-21 2009-07-02 N.V. Nutricia Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota

Also Published As

Publication number Publication date
CA2770099A1 (en) 2011-02-24
EP2467031B1 (en) 2014-09-24
EP2467031A1 (en) 2012-06-27
US9049881B2 (en) 2015-06-09
CL2012000417A1 (en) 2012-09-28
PT2467031E (en) 2014-10-30
US20120148629A1 (en) 2012-06-14
MX2012002039A (en) 2012-04-11
WO2011020780A1 (en) 2011-02-24
TW201117733A (en) 2011-06-01
CN102695427B (en) 2016-04-13
ES2518490T3 (en) 2014-11-05
RU2012110168A (en) 2013-09-27
AU2010285068A1 (en) 2012-03-29
BR112012003706A2 (en) 2015-09-01
PL2467031T3 (en) 2015-03-31
ZA201202009B (en) 2014-08-27
CN102695427A (en) 2012-09-26
AU2010285068B2 (en) 2015-05-28
SG178139A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
IN2012DN00878A (en)
MY163002A (en) A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
PH12014501749A1 (en) A nutritional composition comprising probiotics and improving sleep patterns
MX2022013835A (en) Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2021014138A (en) Methods of using human milk oligosaccharides for improving airway respiratory health.
MX2011007872A (en) Nutritional composition for children with reflux, colic and/or constipation.
MX339112B (en) Infant and young children feeding formula comprising probiotics for infants and young children.
MY197622A (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
HK1160730A1 (en) Probiotic infant products
MX2013005338A (en) Array of age-tailored nutritional formula with probiotics.
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
IN2013DN03771A (en)
MY175195A (en) Nutritional compositions
CA2817217A1 (en) Powdered cereal compositions comprising non-replicating probiotic microorganisms
MY182335A (en) Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2016006503A (en) Heat-treated formulation of >bifidobacterium lactis ncc 2818 reduces allergic manifestations.
MX2011011015A (en) A nutritional composition comprising an apple extract and reducing food allergy symptoms, especially in children.
MX347403B (en) Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses.
TH123975B (en) Composition of nutrition, which consists of apple extract. And reducing symptoms of food allergies, especially in children
TH134768A (en) Nutritional composition, which includes Lactococcus species and reduces food allergy symptoms, especially in infants and children.
PH12017500873A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides